Latest filing published 16 Sept 2026 for TRAVERE THERAPEUTICS INC, €6.1M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
William Rote: trading record in brief
All filings by William Rote on record concern Travere Therapeutics, Inc. Between 15 September 2026 and 16 September 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 16 September 2026, the filings show a transaction worth €6.1M in Travere Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to William Rote
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 112,850 shares@ US$62.51CommonSEC144:0001950047-26-009577
- 96,198 shares@ US$65.790.10% mcap100.0% of flowCommonSEC144:0001950047-26-009503
2 of 2 declarations
